MetaADEDB 2.0 @ LMMD
methsuximide
(AJXPJJZHWIXJCJ-UHFFFAOYSA-N)
Structure
SMILES
CN1C(=O)CC(C1=O)(C)c1ccccc1
Type(s)
Approved
ATC code(s)
N03AD03
Molecular Formula:
C12H13NO2
Molecular Weight:
203.237
Log P:
1.2709
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
37.38
CAS Number(s):
77-41-8
Synonym(s)
1.
methsuximide
2.
Celontin
3.
N,2-dimethyl-2-phenylsuccinimide
4.
Petinutin
5.
mesuximid
6.
mesuximide
7.
methsuximide, (+)-isomer
8.
methsuximide, (+-)-isomer
9.
methsuximide, (-)-isomer
External Link(s)
MeSHC100286
PubChem Compound6476
ChEBI6846
CHEMBLCHEMBL697
DrugBankDB05246
DrugCentral1758
IUPHAR/BPS Guide to PHARMACOLOGY7228
KEGGdr:D00404
Therapeutic Target DatabaseD08EOD
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 3US FAERS
2Drug level decreasedFAERS: 3US FAERS
3Pharmaceutical product complaintFAERS: 3US FAERS
4Product physical issueFAERS: 3US FAERS
5SomnolenceFAERS: 3SIDER
US FAERS
6StressFAERS: 3US FAERS
7AnxietyFAERS: 2US FAERS
8DysgeusiaFAERS: 2US FAERS
9Emotional disorderFAERS: 2US FAERS
10Enzyme abnormalityFAERS: 2US FAERS
11FatigueFAERS: 2US FAERS
12MalaiseFAERS: 2US FAERS
13Poor quality product administeredFAERS: 2US FAERS
14Abdominal discomfortFAERS: 1US FAERS
15AngioedemaFAERS: 1US FAERS
16AstheniaFAERS: 1US FAERS
17CryingFAERS: 1US FAERS
18DizzinessFAERS: 1SIDER
US FAERS
19Electroencephalogram abnormalFAERS: 1US FAERS
20EndocarditisFAERS: 1US FAERS
21Histrionic Personality DisorderFAERS: 1US FAERS
22Incorrect product storageFAERS: 1US FAERS
23Increased tendency to bruiseFAERS: 1US FAERS
24LethargyFAERS: 1US FAERS
25Lip swellingFAERS: 1US FAERS
26MalabsorptionFAERS: 1US FAERS
27Medication ErrorFAERS: 1US FAERS
28Memory impairmentFAERS: 1US FAERS
29PainFAERS: 1US FAERS
30Personality ChangeFAERS: 1US FAERS
31PneumoniaFAERS: 1US FAERS
32Poor quality drug administeredFAERS: 1US FAERS
33Product quality issueFAERS: 1US FAERS
34Respiratory FailureFAERS: 1US FAERS
35Therapeutic product effect incompleteFAERS: 1US FAERS
36Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
37UrticariaFAERS: 1SIDER
US FAERS
38VomitingFAERS: 1SIDER
US FAERS
39Weight decreasedFAERS: 1SIDER
US FAERS
40Wrong technique in drug usage processFAERS: 1US FAERS
41Abdominal PainSIDER
42AnorexiaSIDER
43AtaxiaSIDER
44ConstipationSIDER
45DermatitisSIDER
46DrowsinessSIDER
47Drug Overdose4740029CTD
48Dyskinesia, Drug-Induced6811702CTD
49EosinophiliaSIDER
50Erythema MultiformeSIDER
51Feeling abnormalSIDER
52Gastrointestinal PainSIDER
53HeadacheSIDER
54LeukopeniaSIDER
55Microscopic hematuriaSIDER
56MonocytosisSIDER
57NauseaSIDER
58NervousnessSIDER
59PancytopeniaSIDER
60PhotophobiaSIDER
61Protein urine presentSIDER
62ProteinuriaSIDER
63Seizures4740029CTD
64Stevens-Johnson Syndrome25811541CTD
SIDER
65TensionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.